U.S. Healthcare Technologies Competitiveness Act of 2006

H.R. 5115, the U.S. Healthcare Technologies Competitiveness Act of 2006, proposed a series of tax incentives and credits designed to stimulate investment in the biomedical and biotechnology sectors. The bill aimed to encourage medical innovation by allowing companies to more easily deduct research expenses, offset losses against their taxes, and receive credits for developing treatments for rare diseases. For the average citizen, the bill was intended to accelerate the development of new medical technologies, drugs, and therapies by making it financially more attractive for investors and corporations to fund high-risk medical research. While the legislation sought to strengthen the domestic healthcare technology industry, it did not advance past the committee stage during the 109th Congress.